Edward Albini
2021
In 2021, Edward Albini earned a total compensation of $2.1M as Chief Financial Officer at SUTRO BIOPHARMA.
Compensation breakdown
| Non-Equity Incentive Plan | $176,400 |
|---|---|
| Option Awards | $748,500 |
| Salary | $420,000 |
| Stock Awards | $738,850 |
| Total | $2,083,750 |
Albini received $748.5K in option awards, accounting for 36% of the total pay in 2021.
Albini also received $176.4K in non-equity incentive plan, $420K in salary and $738.9K in stock awards.
Rankings
In 2021, Edward Albini's compensation ranked 5,896th out of 12,415 executives tracked by ExecPay. In other words, Albini earned more than 52.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,896 out of 12,415 | 53rd |
Division Manufacturing | 2,492 out of 5,508 | 55th |
Major group Chemicals And Allied Products | 1,083 out of 2,378 | 55th |
Industry group Drugs | 964 out of 2,099 | 54th |
Industry Biological Products, Except Diagnostic Substances | 235 out of 449 | 48th |
Source: SEC filing on April 22, 2022.
Albini's colleagues
We found four more compensation records of executives who worked with Edward Albini at SUTRO BIOPHARMA in 2021.